# Understanding the biological mechanisms of cancer treatment-induced cardiac toxicity

**Authors:** Eric H. Yang, Rachel E. Ohman

PMC · DOI: 10.1016/j.ahjo.2022.100177 · American Heart Hournal Plus: Cardiology Research and Practice · 2022-07-13

## TL;DR

This paper discusses how to better understand and prevent heart damage caused by cancer treatments.

## Contribution

The paper highlights the need to shift cardio-oncology from reactive to preventative approaches.

## Key findings

- Current knowledge gaps hinder optimal detection and treatment of cardiotoxicity.
- Collaboration across disciplines can transform cardio-oncology into a preventative science.

## Abstract

While many strides have been made in the multidisciplinary science of Cardio-Oncology, gaps in knowledge remain despite these advances to identify optimal strategies of detection and treatment of cancer treatment-associated cardiotoxicity. Many opportunities are available for advocates from all avenues of the field to transform cardio-oncology from a reactionary to a preventative science.

## Full-text entities

- **Diseases:** cancer (MESH:D009369), cardiac toxicity (MESH:D066126)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10978326/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10978326/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC10978326/full.md

---
Source: https://tomesphere.com/paper/PMC10978326